Title:
【発明の名称】乾癬治療用プロテアーゼ阻害因子
Document Type and Number:
Japanese Patent JP2002522396
Kind Code:
A
Abstract:
Psoriasis may be treated by topical administration of a urokinase inhibitor, such as PAI-2, or a combination of protease inhibitors, such as PAI-2 with other serine protease inhibitors and/or with protease inhibitors such as inhibitors of metalloproteinases, acid proteases, and thiol proteases.
Inventors:
Bun Clive Leighton
Sharp Philip John
Sharp Philip John
Application Number:
JP2000563303A
Publication Date:
July 23, 2002
Filing Date:
August 05, 1999
Export Citation:
Assignee:
Biotech Australia Pty Limited
International Classes:
A61K9/06; A61K38/55; A61K38/57; A61K45/00; A61K47/10; A61K47/34; A61K47/48; A61P17/06; (IPC1-7): A61K45/00; A61K9/06; A61K38/55; A61K47/10; A61K47/34; A61K47/48; A61P17/06
Attorney, Agent or Firm:
Shohei Oguri (4 outside)